India's benchmark Nifty 50 index is set to open marginally higher on Thursday after sinking into correction territory in the ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug ...

Several major stocks such as Grasim, Hero MotoCorp, and Honasa Consumer are likely to draw attention due to company updates ...

Here's the complete list of investment and trading ideas for the day. Buy Garden Reach shares in the cash segment for a ...

EBITDA for the quarter stood flat at Rs 1,087.7 crore, while margins contracted to 25.5 per cent. Cipla: Following an ...

NSE's Nifty50 tumbled 324.40 points, or 1.36 per cent, to close at 23,559.05 for the day. Some buzzing pharma stocks ...

GIFT Nifty was trading marginally up, 5 points or 0.02% at 23,649 indicating a muted start for domestic indices. Here are the top stocks to watch for the day.

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, ...

Stock Market Today: Cipla share price gained 10% in the morning trade on Thursday, October 31 after the company announced that its Goa facility has been classified as Voluntary Action Indicated (VAI).

Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI ...